DR. MARTIN WELSCHOF

Commercial Advisory Member

Immunology and DNA sequencing expert

CEO – Bioinvent AB – A Public Immuno-Oncology Company

Board member of APIM Therapeutics AS, Nextera AS & Uni Targeting

Ph.D. Recombinant Antibody Technology, University of Heidelberg